ConductScience.org, home

Paper36205166

Anti-osteoporotic treatment after hip fracture remains alarmingly low.

Kjær N and 2 others. Dan Med J, 2022. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Anti-osteoporotic treatment after hip fracture remains alarmingly low. Papers, record 36205166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36205166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-osteoporotic treatment after hip fracture remains alarmingly low.
PubMed
Journal
Dan Med J
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.8
iCite
Revised in PubMed
2023-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kjær NNanna
2Stabel SSusanne
3Midttun MMette

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hip FracturesMajor topic
OsteoporosisMajor topic
Osteoporotic FracturesMajor topic
Absorptiometry, Photon
Bone Density
Female
Humans
Incidence

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06041672The Effectiveness of Warm Hand Bath in Improving AnxietyResults

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in37125829Comment: Letter to the editor regarding the article "Anti-osteoporotic treatment after hip fracture remains alarmingly low".https://conductscience.org/library/papers/37125829PubMed
Comment in37125830Comment: Reply to letter to the editor regarding the article "Anti-osteoporotic treatment after hip fracture remains alarmingly low".https://conductscience.org/library/papers/37125830PubMed

Download CSV of comments and corrections

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42579041Association of implementation of secondary fracture prevention incentives after hip fracture and risk of subsequent fracture in real-world practice.Eur Geriatr Med2026https://conductscience.org/library/papers/42579041PubMed
41561052Bone turnover markers (β-CTX, PINP, ALP) in osteoporosis: correlation with bone loss and fracture risk stratification.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41561052PubMed
41559654How prevalent is osteoporosis in a high-risk subgroup? A multicenter study of postmenopausal women hospitalized for fractures in China.BMC Musculoskelet Disord2026https://conductscience.org/library/papers/41559654PubMed
40830796The diagnostic and therapeutic potential of miR-3149 in osteoporotic fractures through SMAD4.J Orthop Surg Res2025https://conductscience.org/library/papers/40830796PubMed
40114297Systematic in-hospital screening and treatment for osteoporosis in a geriatric population with hip fractures.J Hosp Med2025https://conductscience.org/library/papers/40114297PubMed
39457701From Genomics to Metabolomics: Molecular Insights into Osteoporosis for Enhanced Diagnostic and Therapeutic Approaches.Biomedicines2024https://conductscience.org/library/papers/39457701PubMed
38198067Duration of osteoporosis treatment to reduce the risk of subsequent osteoporotic fracture and all-cause mortality in elderly hip fracture patients in a Korean real-world study.Arch Osteoporos2024https://conductscience.org/library/papers/38198067PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36205166

GET https://conductscience.org/api/papers/v1/36205166/authors